Compounds for therapeutic use
US10738018B2 · kind B2 · utility
0Cited by
2References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 7, 2018 |
| Grant date | Aug 11, 2020 |
| Priority date | — |
| Expiry date | May 9, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F11/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Chemical entities of Formula (I): Including enantiomers thereof, wherein R1 has any of the values described herein, and compositions comprising such chemical entities; their preparation; and their use in various methods, including the treatment of depression, pain, cognitive disorders, neurodegenerative disorders, and other neurological and peripheral disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.